Stay Connected. Stay Informed.
Image for representation. | Photo Credit: The Hindu The story so far: The maker of the indigenous coronavirus vaccine, Covaxin, Bharat Biotech International Limited (BBIL), has admitted to an “inadvertent error” in patent filings to protect the vaccine’s Intellectual Property Rights (IPR). One of India’s leading biotechnology companies, it had failed to include scientists from…
Read More “What was the tussle over Covaxin IPR? | Explained” »
Students from various organisation protest over the NEET-UG and UGC-NET examinations issue outside Ministry of Education in New Delhi. | Photo Credit: SHASHI SHEKHAR KASHYAP NEET-PG postponed, CBI to probe NEET-UG allegations, NTA chief removed, as panel set up for agency overhaul With questions being raised about the “integrity of certain competitive examinations”, the Health…
Patent Law provides provisions to rectify such mistakes (Representational) Hyderabad: Bharat Biotech has added the Indian Council of Medical Research (ICMR) as co-owner of the Covid-19 vaccine patent. Notably, Bharat Biotech was working on developing the Covid-19 vaccine as a top priority to ensure product availability at the earliest. The Covid vaccine development of Bharat…
Read More “Bharat Biotech Adds Top Medical Body ICMR As Co-Owner Of Covid Vaccine Patent” »
Bharat Biotech’s Covaxin was one of two Covid-19 vaccines available in India (File). New Delhi: The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who received the India-made Covaxin COVID-19 vaccine reported serious side-effects. The study…
Read More “Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology” »
The safety of Covaxin was also evaluated by the Ministry of Health, said the company. The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects. The Hyderabad-based Bharat Biotech underlined that…
Krishna Ella, Chairman, Bharat Biotech. File | Photo Credit: BIJOY GHOSH The Indian Vaccine Manufacturers Association (IVMA) has announced that Krishna Ella, co-founder and executive chairman of Bharat Biotech, will be the association’s new president for two years from April 2024. A press release from Bharat Biotech said Mr. Ella is taking over the presidency…
Vaccine maker Bharat Biotech is conducting the trials in partnership with Spanish biopharmaceutical company Biofabri. File Clinical trials of Spanish tuberculosis (TB) vaccine MTBVAC have begun in India. Vaccine maker Bharat Biotech is conducting the trials in partnership with Spanish biopharmaceutical company Biofabri that is responsible for clinical and industrial development of the vaccine developed…
Read More “Clinical trials of Spanish tuberculosis vaccine MTBVAC begin in India” »
